Abstract

The variability of the results of EVAR to treat infrarenal abdominal aortic aneurysms (AAA) between registers and controlled randomized trials remains large, in particular in terms of survival and quality of follow-up. Moreover, the majority of the currently available results relate to old generation stentgrafts. This multicentric post-inscription observational study evaluated the mid-term results of the new generation Anaconda stentgraft in the treatment of infrarenal AAA under practical conditions of use.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call